16:02 Dec 20
Syngene International Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Syngene International Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
66/100
High Financial Strength
Valuation
20/100
Expensive Valuation
Technical
50/100
Technically Neutral
Strength
8
Weakness
7
Opportunity
1
Threats
2
33.97K
Market Cap (Cr)
70.50
PE Ratio
7.73
Price to Book Ratio
38.09
RSI
14.61 %
Net Profit Margin
Download Our App On:
